Skin News and Research

RSS

Potential drug offers hope for therapy-resistant breast cancer patients

UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.

8 Aug 2017

Prostate cancer cells gain unnatural ability to change shape and spread

Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body.

8 Aug 2017

Tips to follow when you notice signs or symptoms of ringworm

What do athlete's foot, jock itch, and barber's itch all have in common? They are all cases of ringworm, say dermatologists from the American Academy of Dermatology.

8 Aug 2017

Tiny lab-grown structures that resemble amniotic sac may help in infertility research

The first few weeks after sperm meets egg still hold many mysteries. Among them: what causes the process to fail, leading to many cases of infertility.

8 Aug 2017

South Texas fights tuberculosis one blood test at a time

Like most people at Haven for Hope, San Antonio’s largest homeless shelter, James Harrison doesn’t plan on staying long. “I lost my apartment and had nowhere else to go,” he explained.

8 Aug 2017

Study: Media portrayals of pregnant, postpartum women tend to be unrealistic

Whether it's a pregnant character on a TV show or a photo spread heralding a celebrity's rapid recovery of her pre-pregnancy physique, media portrayals of pregnant and postpartum women tend to be unrealistic, women said in a new study.

8 Aug 2017

Nanotechnology wonders: Organ healing with a single touch!

Scientists from the Ohio State University Wexner Medical Centre have come up with what sounds like a science fiction - a nanotechnology device that can switch the cell functions in such a way that the failing organs are revived using a single touch.

7 Aug 2017

Salivary peptide promotes wound healing, research reveals

A study published online in The FASEB Journal delves into the mystifying fact that wounds in your mouth heal faster and more efficiently than wounds elsewhere.

7 Aug 2017

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Researchers at the University of Cincinnati begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells.

7 Aug 2017

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S, to discover novel small molecule leads for multiple therapeutic targets of interest to LEO Pharma.

7 Aug 2017

New LF-OCT technology enables more accurate imaging of cellular processes in the eye

Optical Coherence Tomography (OCT) is a high-resolution live imaging technique that can be used for early detection of retinal diseases, such as age-related macular degeneration, diabetes-related conditions, glaucoma or vascular occlusions, for example.

7 Aug 2017

Band-Aid sized device produces sweat even when patient is relaxed and cool

One downside to medical sensors that test human sweat: you have to sweat. Sweating from exertion or a stifling room temperature can be impractical for some patients and unsafe for others.

4 Aug 2017

Protein that protects fetus during pregnancy could help treat atopic dermatitis

A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases.

4 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Gene-therapy administered through skin transplants could enable treatment of many diseases

A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases.

3 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Kitchen sponges - play house for millions of bacteria - fresh study reports

Scientists in Germany have looked into the minute pores of a common kitchen sponge and found dreaded bacteria that could make us very ill. This is the first comprehensive study to do so. The study was published this week in Scientific Reports. Researchers write that humans spend most of their time in built environments or BE and the microbial presence in these environments is termed BE microbiome. These microbes may have a great impact on human health and wellbeing.

2 Aug 2017